Senate Clears Hamburg for FDA | GenomeWeb

NEW YORK (GenomeWeb News) – The US Senate yesterday confirmed Margaret Hamburg, a biothreat expert with experience running a large organization in New York, and with studying pathogens at the National Institutes of Health, to take over as commissioner at the Food and Drug Administration.

Department of Health and Human Services Director Kathleen Sebelius in a statement called Hamburg "an inspiring public health leader with broad experience in infectious disease, bioterrorism, and health policy. "Her expertise and judgment will serve FDA well," Sebelius said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.